Pramod Tripathi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pramod Tripathi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Baby Sharma
Department of Research, Freedom From Diabetes Research Foundation, Pune, Maharashtra, India
7 shared publications - Nidhi Kadam
Affiliation Department of Research, Freedom from Diabetes Research Foundation, Pune, Maharashtra, India
7 shared publications - Anagha Vyawahare
Department of Research, Freedom from Diabetes Research Foundation, Pune, India
5 shared publications - Diptika Tiwari
Department of Research, Freedom from Diabetes Research Foundation, Pune, India
5 shared publications - Malhar Ganla
Department of Management, Freedom From Diabetes, Pune, Maharashtra, India
5 shared publications - Thejas Kathrikolly
Department of Research, Freedom From Diabetes Research Foundation, Pune, Maharashtra, India
5 shared publications
Latest Publications
- Open Access
- 25 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Baseline clinical and biochemical profiles of type 2 diabetes patients enrolled in a lifestyle management program in India, a cross-sectional study
Assessing the clinical and biochemical profiles of patients with type-2 diabetes (T2D) is vital for understanding the disease characteristics and improving disease management. This study aimed to assess the profiles of adults (> 18 years old) with T2D enrolled in a one-year diabetes management program in Pune, India. This cross-sectional study retrospectively analyzed 18,950 records from the Freedom from Diabetes Clinic, between November 2015 and June 2023. Baseline sociodemographic, biochemical, and anthropometric parameters were extracted from electronic medical records and analyzed using descriptive statistical methods. A gender-wise comparison was performed for the biochemical and anthropometric measurements. Poor glycemic control (glycated hemoglobin [HbA1c] ≥ 7%) was reported by 70.0% of the patients at baseline, despite the majority (80.2%) being on glucose lowering medications. The prevalence of overweight (body mass index [BMI] 23.0–24.9 kg/m2) and obesity (BMI ≥ 25 kg/m2) was 21.5% and 57.2%, respectively. Hypertension and hypercholesterolemia were reported in 56.8% and 25.7% of the patients, respectively. A significant association was observed between comorbidities such as hypertension, overweight/obesity, and poor glycemic control (p < 0.05). Additionally, significant gender-wise differences were observed in the clinical parameters, including homeostatic model assessment of insulin resistance, fasting insulin, and micronutrients (p < 0.05). This study highlights the high prevalence of poor glycemic control, overweight/obesity, and comorbidities among T2D patients enrolled in a one-year diabetes management program in India. Gender-specific differences emphasize the need for tailored management approaches. These findings underscore the importance of comprehensive lifestyle interventions to improve glycemic control, address comorbidities, and reduce complication risks in the Indian population with T2D.
- 25 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Open AccessBaseline clinical and biochemical profiles of type 2 diabetes patients enrolled in a lifestyle management program in India, a cross-sectional study
Assessing the clinical and biochemical profiles of patients with type-2 diabetes (T2D) is vital for understanding the disease characteristics and improving disease management. This study aimed to assess the profiles of adults (> 18 years old) with T2D enrolled in a one-year diabetes management program in Pune, India. This cross-sectional study retrospectively analyzed 18,950 records from the Freedom from Diabetes Clinic, between November 2015 and June 2023. Baseline sociodemographic, biochemical, and anthropometric parameters were extracted from electronic medical records and analyzed using descriptive statistical methods. A gender-wise comparison was performed for the biochemical and anthropometric measurements. Poor glycemic control (glycated hemoglobin [HbA1c] ≥ 7%) was reported by 70.0% of the patients at baseline, despite the majority (80.2%) being on glucose lowering medications. The prevalence of overweight (body mass index [BMI] 23.0–24.9 kg/m2) and obesity (BMI ≥ 25 kg/m2) was 21.5% and 57.2%, respectively. Hypertension and hypercholesterolemia were reported in 56.8% and 25.7% of the patients, respectively. A significant association was observed between comorbidities such as hypertension, overweight/obesity, and poor glycemic control (p < 0.05). Additionally, significant gender-wise differences were observed in the clinical parameters, including homeostatic model assessment of insulin resistance, fasting insulin, and micronutrients (p < 0.05). This study highlights the high prevalence of poor glycemic control, overweight/obesity, and comorbidities among T2D patients enrolled in a one-year diabetes management program in India. Gender-specific differences emphasize the need for tailored management approaches. These findings underscore the importance of comprehensive lifestyle interventions to improve glycemic control, address comorbidities, and reduce complication risks in the Indian population with T2D.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Retrospective Evaluation of the Impact of a Multidisciplinary One‐Year Online Lifestyle Intervention on Type 2 Diabetes Remission in Nonobese Indian Patients
Background and Objective: Despite the high prevalence of T2D among nonobese Indians, there is a notable lack of comprehensive lifestyle intervention studies that target this population. This retrospective study was aimed at filling this gap by evaluating the impact of a multidisciplinary 1‐year online intensive lifestyle intervention (ILI) on T2D remission in nonobese Indian patients. Methodology: Retrospective data from medical records of 1453 nonobese patients (BMI 18.5–24.9 kg/m 2 ) (aged > 18 years) who participated in a 1‐year online subscription‐based ILI program at the Freedom from Diabetes Clinic, India, between June 2020 and October 2023 were extracted for analysis. The program included a plant‐based diet, physical activity regimens, psychological support, and medical management. Homeostatic model assessment of insulin resistance (HOMA2‐IR) and beta cell function (HOMA2%B) were calculated. Remission was defined as maintaining glycated hemoglobin (HbA1C) < 6.5%, measured at least 3 months after cessation of glucose‐lowering pharmacotherapy. Results: The study included 1453 patients (72% male), with a median age of 53 years (IQR: 15), BMI of 23 kg/m 2 (IQR: 2.2), and diabetes duration of 10.5 years (IQR: 10.4). Postintervention, significant changes were observed, including a reduction in weight (−1.5 kg), fasting blood glucose (−13.2 mg/dL), fasting insulin (−0.4 μ U/mL), HOMA2‐IR (−0.07), and HbA1c (−1.2%), along with an increase in HOMA2%B (+3.1) ( p < 0.05). Remission was observed in 24% of the patients. The study identified the baseline predictors of remission as being over 40 years of age at onset, having a diabetes duration of less than 6 years, maintaining good glycemic control (HbA1C ≤ 7%), and being drug‐naïve. Postintervention factors, such as weight loss and improved beta cell function, were also significant predictors of remission ( p < 0.05). Conclusion: These findings suggest that a multidisciplinary lifestyle intervention program can significantly improve glycemic control and promote T2D remission in nonobese Indian patients in a real‐world setting, thereby highlighting the importance of early intervention and weight management in this population. Trial Registration: Clinical Trials Registry of India identifier: CTRI/2024/03/064596
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Open AccessRetrospective Evaluation of the Impact of a Multidisciplinary One‐Year Online Lifestyle Intervention on Type 2 Diabetes Remission in Nonobese Indian Patients
Background and Objective: Despite the high prevalence of T2D among nonobese Indians, there is a notable lack of comprehensive lifestyle intervention studies that target this population. This retrospective study was aimed at filling this gap by evaluating the impact of a multidisciplinary 1‐year online intensive lifestyle intervention (ILI) on T2D remission in nonobese Indian patients. Methodology: Retrospective data from medical records of 1453 nonobese patients (BMI 18.5–24.9 kg/m 2 ) (aged > 18 years) who participated in a 1‐year online subscription‐based ILI program at the Freedom from Diabetes Clinic, India, between June 2020 and October 2023 were extracted for analysis. The program included a plant‐based diet, physical activity regimens, psychological support, and medical management. Homeostatic model assessment of insulin resistance (HOMA2‐IR) and beta cell function (HOMA2%B) were calculated. Remission was defined as maintaining glycated hemoglobin (HbA1C) < 6.5%, measured at least 3 months after cessation of glucose‐lowering pharmacotherapy. Results: The study included 1453 patients (72% male), with a median age of 53 years (IQR: 15), BMI of 23 kg/m 2 (IQR: 2.2), and diabetes duration of 10.5 years (IQR: 10.4). Postintervention, significant changes were observed, including a reduction in weight (−1.5 kg), fasting blood glucose (−13.2 mg/dL), fasting insulin (−0.4 μ U/mL), HOMA2‐IR (−0.07), and HbA1c (−1.2%), along with an increase in HOMA2%B (+3.1) ( p < 0.05). Remission was observed in 24% of the patients. The study identified the baseline predictors of remission as being over 40 years of age at onset, having a diabetes duration of less than 6 years, maintaining good glycemic control (HbA1C ≤ 7%), and being drug‐naïve. Postintervention factors, such as weight loss and improved beta cell function, were also significant predictors of remission ( p < 0.05). Conclusion: These findings suggest that a multidisciplinary lifestyle intervention program can significantly improve glycemic control and promote T2D remission in nonobese Indian patients in a real‐world setting, thereby highlighting the importance of early intervention and weight management in this population. Trial Registration: Clinical Trials Registry of India identifier: CTRI/2024/03/064596
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Retrospective Analysis of the Efficacy of Integrated Lifestyle Modifications in Managing Prediabetes in the Indian Population
Background: Prediabetes is a growing health concern in India, with a prevalence of 15.3%. This retrospective study was aimed at assessing the effectiveness of an integrated intensive lifestyle intervention (ILI) in Indian patients with prediabetes while exploring sex‐ and body mass index (BMI)–based differences. Methods: This retrospective study analyzed data from 427 patients with prediabetes (HbA1c: 5.7%–6.4% not on insulin or oral hypoglycemic agents and aged 18–75 years) who underwent a 1‐year online ILI program at the Freedom from Diabetes Clinic, India, between 2020 and 2023. The intervention consisted of a personalized plant‐based diet, physical activity, psychological support, and medical management. Anthropometric and biochemical data were extracted from the clinical database, and logistic regression was used to identify factors associated with prediabetes remission. Results: At the end of the study, 47.1% of patients achieved prediabetes remission. Significant weight loss and improvements were observed in HbA1c, BMI, fasting blood glucose, fasting insulin, insulin resistance, lipid profile, and blood pressure ( p < 0.05). Notably, 34% of patients lost > 10% of their body weight. Females achieved greater reductions in weight and BMI than males ( p < 0.001). The BMI stratified analysis revealed higher remission rates in the obesity group (BMI ≥ 25 kg/m 2 ) (49.9%) than in the nonobesity group (BMI 18–24.9 kg/m 2 ) (37.0%) ( p = 0.028). The obesity group showed greater improvements in glycemic parameters and insulin resistance than the nonobesity group ( p < 0.05). Logistic regression identified age ≤ 50 years (OR: 2.15, 95% CI: 1.42–3.27), endline HOMA‐IR < 2.5 (OR: 1.60, 95% CI: 1.01–2.45), and > 10% weight loss (OR: 3.72, 95% CI: 2.34–5.90) as significant factors associated with prediabetes remission. Conclusions: Prediabetes remission was achieved in almost half of the patients, highlighting the effectiveness of a tailored multidisciplinary approach for managing prediabetes in the Indian population. The study showed significant weight loss, improved glycemic control, and better lipid profiles and emphasized the need for personalized strategies for prediabetes management considering factors such as sex and BMI. Trial Registration: Clinical Trials Registry of India identifier: CTRI/2024/03/064596
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Open AccessRetrospective Analysis of the Efficacy of Integrated Lifestyle Modifications in Managing Prediabetes in the Indian Population
Background: Prediabetes is a growing health concern in India, with a prevalence of 15.3%. This retrospective study was aimed at assessing the effectiveness of an integrated intensive lifestyle intervention (ILI) in Indian patients with prediabetes while exploring sex‐ and body mass index (BMI)–based differences. Methods: This retrospective study analyzed data from 427 patients with prediabetes (HbA1c: 5.7%–6.4% not on insulin or oral hypoglycemic agents and aged 18–75 years) who underwent a 1‐year online ILI program at the Freedom from Diabetes Clinic, India, between 2020 and 2023. The intervention consisted of a personalized plant‐based diet, physical activity, psychological support, and medical management. Anthropometric and biochemical data were extracted from the clinical database, and logistic regression was used to identify factors associated with prediabetes remission. Results: At the end of the study, 47.1% of patients achieved prediabetes remission. Significant weight loss and improvements were observed in HbA1c, BMI, fasting blood glucose, fasting insulin, insulin resistance, lipid profile, and blood pressure ( p < 0.05). Notably, 34% of patients lost > 10% of their body weight. Females achieved greater reductions in weight and BMI than males ( p < 0.001). The BMI stratified analysis revealed higher remission rates in the obesity group (BMI ≥ 25 kg/m 2 ) (49.9%) than in the nonobesity group (BMI 18–24.9 kg/m 2 ) (37.0%) ( p = 0.028). The obesity group showed greater improvements in glycemic parameters and insulin resistance than the nonobesity group ( p < 0.05). Logistic regression identified age ≤ 50 years (OR: 2.15, 95% CI: 1.42–3.27), endline HOMA‐IR < 2.5 (OR: 1.60, 95% CI: 1.01–2.45), and > 10% weight loss (OR: 3.72, 95% CI: 2.34–5.90) as significant factors associated with prediabetes remission. Conclusions: Prediabetes remission was achieved in almost half of the patients, highlighting the effectiveness of a tailored multidisciplinary approach for managing prediabetes in the Indian population. The study showed significant weight loss, improved glycemic control, and better lipid profiles and emphasized the need for personalized strategies for prediabetes management considering factors such as sex and BMI. Trial Registration: Clinical Trials Registry of India identifier: CTRI/2024/03/064596
- Open Access
- 30 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Psychometric validation of type 2 Diabetes Distress Assessment System in an Indian type 2 diabetes population
Diabetes distress (DD) significantly burdens and negatively impacts self-management and health outcomes in patients with type 2 diabetes (T2D). Early detection and management of DD are crucial for effective T2D management. The Diabetes Distress Assessment System (T2-DDAS) is a recently validated tool for measuring DD, but its psychometric properties in non-Western populations, such as India, have not been evaluated. This study aimed to assess the validity and reliability of T2-DDAS in Indian patients with T2D. Data from 408 T2D patients enrolled in a one-year diabetes management program at the Freedom from Diabetes Clinic in Pune, India, from January to March 2024, were analyzed. Sociodemographic characteristics, medical history, and anthropometric parameters were extracted from existing records. T2-DDAS, previously validated in a Western population, was administered. Statistical analyses included descriptive statistics, Principal Component Analysis (PCA), Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), and Structural Equation Modeling (SEM), using IBM SPSS, R, and AMOS software. The T2-DDAS demonstrated good internal consistency (Cronbach’s α = 0.91). CFA yielded satisfactory fit indices (χ² = 1036.92, RMSEA = 0.07, TLI = 0.905, CFI = 0.918), supporting the construct validity of T2-DDAS for the Indian population. The T2-DDAS is a valid and reliable tool for assessing DD in Indian patients with T2D.
- 30 December 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessPsychometric validation of type 2 Diabetes Distress Assessment System in an Indian type 2 diabetes population
Diabetes distress (DD) significantly burdens and negatively impacts self-management and health outcomes in patients with type 2 diabetes (T2D). Early detection and management of DD are crucial for effective T2D management. The Diabetes Distress Assessment System (T2-DDAS) is a recently validated tool for measuring DD, but its psychometric properties in non-Western populations, such as India, have not been evaluated. This study aimed to assess the validity and reliability of T2-DDAS in Indian patients with T2D. Data from 408 T2D patients enrolled in a one-year diabetes management program at the Freedom from Diabetes Clinic in Pune, India, from January to March 2024, were analyzed. Sociodemographic characteristics, medical history, and anthropometric parameters were extracted from existing records. T2-DDAS, previously validated in a Western population, was administered. Statistical analyses included descriptive statistics, Principal Component Analysis (PCA), Exploratory Factor Analysis (EFA), Confirmatory Factor Analysis (CFA), and Structural Equation Modeling (SEM), using IBM SPSS, R, and AMOS software. The T2-DDAS demonstrated good internal consistency (Cronbach’s α = 0.91). CFA yielded satisfactory fit indices (χ² = 1036.92, RMSEA = 0.07, TLI = 0.905, CFI = 0.918), supporting the construct validity of T2-DDAS for the Indian population. The T2-DDAS is a valid and reliable tool for assessing DD in Indian patients with T2D.
- Open Access
- 7 November 2024
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 2 (12) , luae210
Diabetes Remission After Radical Nephrectomy in a Geriatric Patient With Obesity and Type 2 Diabetes—34 Months’ Follow-Up
Diabetes mellitus significantly affects survival in patients with renal cell carcinoma undergoing nephrectomy, requiring personalized care. This case involved a 64-year-old man with type 2 diabetes (T2D) who underwent radical nephrectomy for renal cell carcinoma. He consented to a 1-year intensive lifestyle intervention (ILI), including a vegan diet (to lower calorie intake, reduce uric acid, support renal health, and promote weight loss), intermittent fasting, regular exercise, psychological support, and medical management. Quarterly biochemical assessments and monthly adherence evaluations were conducted. Post intervention, the patient achieved diabetes remission, maintaining glycated hemoglobin A1c (HbA1c) below 6.5% (48 mmol/mol) (reference range, <6.5%; <48 mmol/mol) without medication. He lost 36 kg (79.37 lb), reducing his body mass index from 35.3 to 25.1. His lipid profile normalized (total cholesterol, 175 to 127 mg/dL (4.53 to 3.29 mmol/L) (reference range, <200 mg/dL; <5.18 mmol/L); triglycerides, 155 to 73 mg/dL (1.75 to 0.82 mmol/L) (reference range, <150 mg/dL; <1.69 mmol/L), allowing the discontinuation of statins. Improvements in serum creatinine and high-sensitivity C-reactive protein levels were also observed. The patient exhibited normal glucose tolerance, consecutively passing an oral glucose tolerance test for 2 years. This case highlights the potential of lifestyle modifications in managing T2D in patients with a history of nephrectomy.
- 7 November 2024
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 2 (12) , luae210
Open AccessDiabetes Remission After Radical Nephrectomy in a Geriatric Patient With Obesity and Type 2 Diabetes—34 Months’ Follow-Up
Diabetes mellitus significantly affects survival in patients with renal cell carcinoma undergoing nephrectomy, requiring personalized care. This case involved a 64-year-old man with type 2 diabetes (T2D) who underwent radical nephrectomy for renal cell carcinoma. He consented to a 1-year intensive lifestyle intervention (ILI), including a vegan diet (to lower calorie intake, reduce uric acid, support renal health, and promote weight loss), intermittent fasting, regular exercise, psychological support, and medical management. Quarterly biochemical assessments and monthly adherence evaluations were conducted. Post intervention, the patient achieved diabetes remission, maintaining glycated hemoglobin A1c (HbA1c) below 6.5% (48 mmol/mol) (reference range, <6.5%; <48 mmol/mol) without medication. He lost 36 kg (79.37 lb), reducing his body mass index from 35.3 to 25.1. His lipid profile normalized (total cholesterol, 175 to 127 mg/dL (4.53 to 3.29 mmol/L) (reference range, <200 mg/dL; <5.18 mmol/L); triglycerides, 155 to 73 mg/dL (1.75 to 0.82 mmol/L) (reference range, <150 mg/dL; <1.69 mmol/L), allowing the discontinuation of statins. Improvements in serum creatinine and high-sensitivity C-reactive protein levels were also observed. The patient exhibited normal glucose tolerance, consecutively passing an oral glucose tolerance test for 2 years. This case highlights the potential of lifestyle modifications in managing T2D in patients with a history of nephrectomy.
- Open Access
- 22 October 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-10
Improvement in symptoms of anxiety and depression in individuals with type 2 diabetes: retrospective analysis of an intensive lifestyle modification program
Type 2 diabetes (T2D) is a chronic metabolic disorder that has a notable influence on mental well-being, contributing to elevated morbidity and mortality rates. Depression and anxiety disorders are the most common mental health concerns among patients with T2D worldwide. Therefore, the present study aimed to assess the impact of an online intensive lifestyle intervention (ILI) on mental health outcomes (depression and anxiety) in patients with T2D in India. This retrospective pre-post analysis included adult patients (aged > 18 years) diagnosed with T2D who were enrolled in a diabetes management program in India between June 2021 and June 2023. The intervention consisted of lifestyle modifications such as a customized plant-based diet, regular physical activity, psychological support through group and individual therapy, and medical management. Data were extracted from the electronic database of the clinic, including anthropometry, medical history, biochemical parameters, symptoms of depression, and anxiety (assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorders-7 (GAD-7) scale) at the start and end of the six-month intervention period. Of the 1061 eligible patients (177 with prediabetes), 40.3% were female. The mean age, duration of diabetes, and HbA1c levels were 52 ± 10.4 years, 9.8 ± 7.8 years, and 8 ± 1.7%, respectively. The prevalence of symptoms of depression and anxiety (ranging from mild to severe) was 46% and 44.3%, respectively, which reduced to 28.7% and 29.2%, respectively, post-intervention. Integrated ILI successfully improved the symptoms of anxiety and depression, highlighting the importance of a multidisciplinary approach that includes diet, physical activity, psychological support, and medical management in enhancing mental health outcomes among patients with T2D. Future prospective studies are needed to explore the long-term effects of such interventions and develop effective strategies for promoting mental health in diverse populations. The study was approved by the Freedom from Diabetes Research Foundation Institutional Ethics Committee (approval number FFDRF/IEC/2024/7) and registered in the Clinical Trials Registry of India (CTRI/2024/03/064596, registered on March 21, 2024).
- 22 October 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-10
Open AccessImprovement in symptoms of anxiety and depression in individuals with type 2 diabetes: retrospective analysis of an intensive lifestyle modification program
Type 2 diabetes (T2D) is a chronic metabolic disorder that has a notable influence on mental well-being, contributing to elevated morbidity and mortality rates. Depression and anxiety disorders are the most common mental health concerns among patients with T2D worldwide. Therefore, the present study aimed to assess the impact of an online intensive lifestyle intervention (ILI) on mental health outcomes (depression and anxiety) in patients with T2D in India. This retrospective pre-post analysis included adult patients (aged > 18 years) diagnosed with T2D who were enrolled in a diabetes management program in India between June 2021 and June 2023. The intervention consisted of lifestyle modifications such as a customized plant-based diet, regular physical activity, psychological support through group and individual therapy, and medical management. Data were extracted from the electronic database of the clinic, including anthropometry, medical history, biochemical parameters, symptoms of depression, and anxiety (assessed using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorders-7 (GAD-7) scale) at the start and end of the six-month intervention period. Of the 1061 eligible patients (177 with prediabetes), 40.3% were female. The mean age, duration of diabetes, and HbA1c levels were 52 ± 10.4 years, 9.8 ± 7.8 years, and 8 ± 1.7%, respectively. The prevalence of symptoms of depression and anxiety (ranging from mild to severe) was 46% and 44.3%, respectively, which reduced to 28.7% and 29.2%, respectively, post-intervention. Integrated ILI successfully improved the symptoms of anxiety and depression, highlighting the importance of a multidisciplinary approach that includes diet, physical activity, psychological support, and medical management in enhancing mental health outcomes among patients with T2D. Future prospective studies are needed to explore the long-term effects of such interventions and develop effective strategies for promoting mental health in diverse populations. The study was approved by the Freedom from Diabetes Research Foundation Institutional Ethics Committee (approval number FFDRF/IEC/2024/7) and registered in the Clinical Trials Registry of India (CTRI/2024/03/064596, registered on March 21, 2024).